Ventas (VTR) to Announce Earnings on Wednesday

Ventas (NYSE:VTR) will likely be posting its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to post earnings of $0.1423 per share and revenue of $1.6808 billion for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the company earned $0.84 EPS. The firm’s revenue was up 22.0% compared to the same quarter last year. On average, analysts expect Ventas to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Ventas Stock Down 0.4%

Shares of NYSE:VTR opened at $100.12 on Tuesday. The company has a market capitalization of $48.67 billion, a price-to-earnings ratio of 182.04, a price-to-earnings-growth ratio of 2.16 and a beta of 0.70. The company has a 50 day moving average of $88.41 and a two-hundred day moving average of $85.08. Ventas has a 52-week low of $65.15 and a 52-week high of $100.98. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th were paid a $0.52 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. Ventas’s dividend payout ratio is 378.18%.

Insider Activity at Ventas

In other news, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the transaction, the director owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the sale, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas

A number of hedge funds have recently added to or reduced their stakes in the business. Keel Point LLC lifted its position in shares of Ventas by 10.7% in the 4th quarter. Keel Point LLC now owns 3,227 shares of the real estate investment trust’s stock worth $250,000 after buying an additional 311 shares during the last quarter. M&G PLC bought a new stake in shares of Ventas during the 4th quarter valued at about $242,000. Morningstar Investment Management LLC acquired a new stake in Ventas during the third quarter worth about $233,000. EntryPoint Capital LLC acquired a new stake in Ventas during the fourth quarter worth about $227,000. Finally, Bridgewater Associates LP acquired a new stake in Ventas during the fourth quarter worth about $220,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on VTR. Barclays started coverage on shares of Ventas in a report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price target for the company. Scotiabank cut their price objective on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Mizuho upped their price objective on shares of Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Royal Bank Of Canada raised their target price on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Finally, Jefferies Financial Group lifted their target price on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Fifteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $96.50.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.